Bank of America’s Aprea Therapeutics APRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.21K | Buy |
4,856
+4
| +0.1% | +$7 | ﹤0.01% | 6197 |
|
|
2025
Q1 | $9.9K | Buy |
4,852
+1
| +0% | +$2 | ﹤0.01% | 6074 |
|
|
2024
Q4 | $16K | Sell |
4,851
-1
| -0% | -$3 | ﹤0.01% | 5982 |
|
|
2024
Q3 | $13.3K | Sell |
4,852
-1
| -0% | -$3 | ﹤0.01% | 5919 |
|
|
2024
Q2 | $19.8K | Buy |
4,853
+3,287
| +210% | +$13.4K | ﹤0.01% | 5870 |
|
|
2024
Q1 | $10.5K | Sell |
1,566
-1,685
| -52% | -$11.3K | ﹤0.01% | 5992 |
|
|
2023
Q4 | $15.3K | Buy |
3,251
+1
| +0% | +$5 | ﹤0.01% | 5901 |
|
|
2023
Q3 | $13.5K | Buy |
+3,250
| New | +$13.5K | ﹤0.01% | 5885 |
|
|
2023
Q2 | – | Sell |
-10
| Closed | -$44 | – | 6788 |
|
|
2023
Q1 | $44 | Sell |
10
-108
| -92% | -$475 | ﹤0.01% | 6689 |
|
|
2022
Q4 | $40 | Buy |
+118
| New | +$40 | ﹤0.01% | 7010 |
|
|
2022
Q3 | – | Sell |
-198
| Closed | – | – | 6908 |
|
|
2022
Q2 | $0 | Sell |
198
-3,985
| -95% | – | ﹤0.01% | 7127 |
|
|
2022
Q1 | $8K | Buy |
4,183
+4,043
| +2,888% | +$7.73K | ﹤0.01% | 6969 |
|
|
2021
Q4 | $0 | Sell |
140
-10,166
| -99% | – | ﹤0.01% | 7293 |
|
|
2021
Q3 | $53K | Buy |
10,306
+4,690
| +84% | +$24.1K | ﹤0.01% | 6126 |
|
|
2021
Q2 | $27K | Sell |
5,616
-3,388
| -38% | -$16.3K | ﹤0.01% | 6233 |
|
|
2021
Q1 | $46K | Buy |
9,004
+6,100
| +210% | +$31.2K | ﹤0.01% | 5971 |
|
|
2020
Q4 | $15K | Sell |
2,904
-83,142
| -97% | -$429K | ﹤0.01% | 5875 |
|
|
2020
Q3 | $2.07M | Buy |
86,046
+33,868
| +65% | +$815K | ﹤0.01% | 3205 |
|
|
2020
Q2 | $2.02M | Sell |
52,178
-993
| -2% | -$38.5K | ﹤0.01% | 3226 |
|
|
2020
Q1 | $1.85M | Buy |
53,171
+52,067
| +4,716% | +$1.81M | ﹤0.01% | 3146 |
|
|
2019
Q4 | $50K | Buy |
+1,104
| New | +$50K | ﹤0.01% | 5433 |
|